Sivakesava Sakhamuri
CIK: 0002158086
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRSP
CRISPR Therapeutics AG
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Sakhamuri Sivakesava
Sakhamuri Sivakesava (SEC CIK 0002158086) files insider reports with the SEC as Chief Technical Officer of CRISPR Therapeutics AG (CRSP).
Signal8 holds 1 ownership filing by Sakhamuri Sivakesava, a Form 3, filed on Nov 2, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Sakhamuri Sivakesava's filings is in BOSTON, MA.
Other insiders filing for CRISPR Therapeutics AG (CRSP)
- Silver Andrew Jacob, Chief Financial Officer
- KASINGER JAMES R., General Counsel and Secretary
- Kulkarni Samarth, Chief Executive Officer
- Patel Naimish, Chief Medical Officer
- George Simeon, Director
- Behbahani Ali, Director